Last fall, as large school systems across the country announced they wouldn’t be bringing students back to school in person, parents worried about the impact on their children’s educational progress and their own ability to work. Some clamored to get students back into school buildings. Others — if they could afford it — sought alternatives
0 Comments
How far can a small medical devices company take a celebrity endorsement? The shares of veterinary diagnostics company Zomedica (NYSEAMERICAN:ZOM) surged after an endorsement from Tiger King celebrity Carole Baskin. In response, meme traders bid ZOM stock up sharply. Since the short interest in ZOM stock is high, the news created a dramatic short squeeze. Source:
0 Comments
The COVID-19 pandemic has put government assistance programs into overdrive, as many people who never needed them before must now use them. Here’s a descriptive list of major government assistance programs for individuals and businesses with links to where and how to apply to them. Key Takeaways The COVID-19 pandemic has put government assistance programs
0 Comments
Dear Moneyist, We just lost my 60-year-old uncle to dementia. He struggled with drugs during his early years, and as a result, my mom raised his daughter. Once he became sober, we were all very close, and we did our best to provide care for him.  His official cause of death was preventable — the
0 Comments
Clover Health (NASDAQ:CLOV) has been one of the year’s biggest disappointments. The so-called King of SPACs (special purpose acquisition companies), Chamath Palihapitiya, took the health insurer public via one of his Social Capital Hedosophia SPACs. CLOV stock shares almost immediately tumbled after short sellers revealed that it had failed to disclose a government investigation into
0 Comments
The COVID-19 pandemic has affected millions of Americans financially. In a survey by the National Endowment for Financial Education (NEFE), three in 10 Americans said paying off debt is their top financial stressor, while 55% were worried about having enough cash tucked away in savings. Though the federal government has introduced numerous measures to provide
0 Comments
Meme stocks aren’t going anywhere anytime soon. One of the most interesting trends to emerge during the pandemic, this subcategory of stocks is generating a lot of interest, especially from retail investors. And that has led to a sharp increase of buying into companies with high short ratios. This is traditional investing turned upside down.
0 Comments
Your calendar may not yet have taken note, so let me be the first to inform you that fall has officially arrived. Not the season that begins this year on Sept. 22. Rather, the fall that begins when Starbucks SBUX, +0.70% starts peddling its autumn beverages. This year, the coffee chain kicked things off on
0 Comments
In this article FISV Oscar Wong | Moment | Getty Images Company: Fiserv Inc. (FISV) Business: Fiserv provides payment and financial services technology worldwide. The company operates through Acceptance, Fintech, and Payments segments. The Acceptance segment provides point-of-sale merchant acquiring and digital commerce services; mobile payment services; security and fraud protection products; Carat, an omnichannel
0 Comments
Outlier Covid-19 vaccine play Ocugen (NASDAQ:OCGN) stock has been on a negative run in the past three months, losing about 17% of its value. Source: Shutterstock The company failed to gain an emergency use authorization (EUA) from the FDA for Covaxin, the Indian variant of the coronavirus vaccine. Moreover, its partner firm Bharat Biotech is
0 Comments
Ahead of its second-quarter earnings report, markets sold off shares of Roblox (NYSE:RBLX). However, the gaming platform allayed fears when it posted respectable results. That said, RBLX stock is still relatively expensive compared to other video game stocks like Activision (NASDAQ:ATVI) or Electronic Arts (NASDAQ:EA). Source: Miguel Lagoa / Shutterstock.com Roblox trades at 19 times
0 Comments